Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials. (Q53172353)
Jump to navigation
Jump to search
scientific article published on 11 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials. |
scientific article published on 11 February 2016 |
Statements
Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials. (English)
1 reference
1 reference
Bruce Strober
1 reference
Georg Popp
1 reference
James Krell
1 reference
Sigitas Stonkus
1 reference
Marcis Septe
1 reference
Boni E Elewski
1 reference
Alice B Gottlieb
1 reference
Yang Zhao
1 reference
Mary H Tran
1 reference
Alexander Karpov
1 reference
Lori D McLeod
1 reference
Margaret Mordin
1 reference
Charis Papavassilis
1 reference
Judit Nyirady
1 reference
Mark Lebwohl
1 reference
11 February 2016
1 reference
55
1 reference
401-407
1 reference
4
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference